8-K
false000185623600018562362024-03-062024-03-06

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): March 6, 2024

EUROPEAN WAX CENTER, INC.

(Exact name of Registrant as Specified in Its Charter)

Delaware

001-40714

86-3150064

(State or Other Jurisdiction

of Incorporation)

(Commission File Number)

(IRS Employer

Identification No.)

 

 

 

5830 Granite Parkway, 3rd Floor

Plano, Texas

75024

(Address of Principal Executive Offices)

(Zip Code)

Registrant’s Telephone Number, Including Area Code: (469) 264-8123

 

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange on which registered

Class A common stock, par value $0.00001 per share

 

EWCZ

 

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 


 

Item 2.02 Results of Operations and Financial Condition.

On March 6, 2024, European Wax Center, Inc. (the “Company”) issued the press release attached hereto as Exhibit 99.1 reporting its financial results for the fiscal year ended January 6, 2024.

All of the information included in Items 2.02 and 9.01 of this report and Exhibit 99.1 hereto is being furnished and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference in any filing under the Securities Act of 1933, as amended (the “Securities Act”) or the Exchange Act, regardless of any general incorporation language in such filings, unless expressly incorporated by specific reference in such filing.

 

Item 9.01 Financial Statements and Exhibits
 

Exhibit

Number

Description

99.1

 

Press release reporting financial results for the fiscal year ended January 6, 2024, issued by European Wax Center, Inc. on March 6, 2024.

104

Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

1


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

EUROPEAN WAX CENTER, INC.

Date: March 6, 2024

By:

/s/ GAVIN M. O'CONNOR

Name: Gavin M. O'Connor

Title: Chief Administrative Officer, General Counsel and Corporate Secretary

 

2


EX-99.1

EXHIBIT 99.1

European Wax Center, Inc. Reports Fourth Quarter and Fiscal Year 2023 Results

Issues fiscal 2024 outlook

Fiscal Year 2023 versus 2022

Net new centers increased 10.6% to 1,044 total centers in 45 states
System-wide sales of $955.0 million increased 6.3%
Total revenue of $221.0 million increased 6.6%
Same-store sales increased 2.9%
GAAP net income of $12.3 million and Adjusted net income of $22.5 million
Adjusted EBITDA of $76.0 million

 

Plano, TX, March 6, 2024 - Today, European Wax Center, Inc. (NASDAQ: EWCZ), the largest and fastest-growing franchisor and operator of out-of-home waxing services in the United States, reports financial results for the 14 and 53 weeks ended January 6, 2024.

David Willis, Chief Executive Officer of European Wax Center, Inc. stated: “European Wax Center delivered a strong fourth quarter and equally strong full year 2023 performance. We opened 100 net new centers in 2023, all of which were developed by existing operators, demonstrating continued demand from our franchisees. Further, our core guests, Wax Pass and routine guests, remained firmly committed to their personal care routines, demonstrated by their recurring, predictable revenue stream comprising more than 75% of our $955 million in full year system-wide sales.”

 

Mr. Willis continued, “Looking ahead, we are entering 2024 with confidence in our model, our loyal core guest base, well-capitalized franchisees, and a deep development pipeline. We expect to deliver another year of top and bottom-line growth, driven by new center openings and in-center sales growth. 2024 is the 20th anniversary of the European Wax Center brand, and we’re excited to extend our position as the undisputed leader in out-of-home hair removal and we expect that we will continue to take share in this highly fragmented category.”

 

Results for the Fourth Quarter of Fiscal 2023 versus Fiscal 2022

Franchisees opened 18 net new centers, and we ended the year with 1,044 centers, representing a 10.6% increase versus 944 centers in prior year period.
System-wide sales of $241.7 million increased 7.2% from $225.4 million in the prior year period, primarily driven by net new centers opened over the past twelve months and increased spend by guests at existing centers.
Total revenue of $56.3 million increased 5.2% from $53.5 million in the prior year period.
Same-store sales increased 1.3%.
Selling, general and administrative expenses (“SG&A”) of $13.7 million decreased 6.0% from $14.6 million in the prior year period. SG&A as a percent of total revenue decreased 290 basis points to 24.4% from 27.3%, primarily due to decreases in technology and insurance costs which were partially offset by increases in payroll and benefits and expenses related to the pilot of laser hair removal.
Interest expense of $6.6 million decreased from $7.2 million in the prior year period, primarily due to an increase in interest income from the Company’s short-term investments.
Income tax expense was $2.2 million compared to an income tax benefit of $53.3 million in the fourth quarter of fiscal 2022. The income tax benefit in fiscal 2022 was primarily attributable to the release of a valuation allowance on deferred tax assets.

 


 

Net income of $3.6 million increased 59.1% from $2.3 million in the prior year period. Adjusted net income of $6.0 million decreased from $48.7 million in the prior year period, primarily due to the income tax benefit recognized in fiscal 2022 from the release of a valuation allowance on deferred tax assets.
Adjusted EBITDA of $19.3 million increased 0.3% from $19.2 million in the prior year period. As a percent of total revenue, Adjusted EBITDA margin decreased 170 basis points to 34.2% from 35.9%.
The Company repurchased $23.6 million of its Class A Common Stock during the period and has cumulatively repurchased the full $40 million authorized under its current share repurchase program.

 

Annual Results for Fiscal 2023 versus Fiscal 2022

Franchisees opened 100 net new centers in fiscal 2023.
System-wide sales of $955.0 million grew 6.3% from $898.6 million in the prior year, primarily driven by net new centers opened over the past twelve months and increased spend by guests at existing centers.
Total revenue of $221.0 million increased 6.6% from $207.4 million in the prior year.
Same-store sales increased 2.9%.
SG&A of $59.5 million increased 0.9% from $59.0 million in the prior year. SG&A as a percent of total revenue improved 150 basis points to 26.9% from 28.4%, primarily due to a reduction in professional fees related to the Company’s refinancing and secondary offering in 2022 and a reduction in technology fees. These reductions were partially offset by increased share-based compensation expense resulting from the modification of certain equity awards in the current year as well as increases in corporate marketing and expenses related to the pilot of laser hair removal.
Interest expense of $26.7 million increased from $23.6 million in the prior year due to higher average principal balances and interest rates following the Company’s refinancing in 2022, partially offset by the nonrecurrence of a $2.0 million loss on debt extinguishment and an increase in interest income from the Company’s short-term investments.
Income tax expense was $6.2 million compared to an income tax benefit of $53.2 million in fiscal 2022. The income tax benefit in fiscal 2022 was primarily attributable to the release of a valuation allowance on deferred tax assets.
Net income of $12.3 million decreased 9.3% from $13.6 million in the prior year. Adjusted net income of $22.5 million decreased from $71.5 million in the prior year, primarily due to the income tax benefit recognized in fiscal 2022 from the release of a valuation allowance on deferred tax assets.
Adjusted EBITDA of $76.0 million increased 6.1% from $71.6 million in the prior year. As a percent of total revenue, Adjusted EBITDA margin decreased 10 basis points to 34.4% from 34.5%.

 

Balance Sheet and Cash Flow

The Company ended the year with $52.7 million in cash and cash equivalents, $6.5 million in restricted cash, $394.0 million in borrowings outstanding under its senior secured notes and no outstanding borrowings under its revolving credit facility. Net cash provided by operating activities totaled $55.6 million during fiscal 2023.

 


 

Fiscal 2024 Outlook(1)

The Company provides the following outlook for fiscal year 2024:

Fiscal 2024 Outlook

New Center Openings, Net

75 to 80

System-Wide Sales

$1,000 million to $1,025 million

Total Revenue

$225 million to $232 million

Same-Store Sales

2% to 5%

Adjusted Net Income(2)

$22 million to $25 million

Adjusted EBITDA(3)

$75 million to $80 million

 

(1) Fiscal 2022 and Fiscal 2023 each included a 53rd week in the fourth quarter. The Company estimates the 53rd week contribution to the top and bottom line is approximately equal to the contribution from an average fourth quarter week. The Company’s current outlook assumes no meaningful change in consumer behavior driven by inflationary pressures and no further impacts from incremental tightening in the labor market beyond what we see today.

(2) Adjusted net income outlook assumes an effective tax rate of approximately 25% for Fiscal 2024 computed by applying our estimated blended statutory tax rate and incorporating the effect of nondeductible and other rate impacting adjustments.

(3) Adjusted EBITDA includes approximately $4 million of costs related to the Company’s investment in laser.

See “Disclosure Regarding Non-GAAP Financial Measures” and the reconciliation tables that accompany this release for a discussion and reconciliation of certain non-GAAP financial measures included in this release.


Webcast and Conference Call Information

European Wax Center, Inc. will host a conference call to discuss fourth quarter and fiscal 2023 results today, March 6, 2024, at 8:00 a.m. ET/7:00 a.m. CT. To access the conference call dial-in information, analysts should click here to register online at least 15 minutes before the start of the call. All other participants are asked to access the earnings webcast via https://investors.waxcenter.com. A replay of the webcast will be available two hours after the call and archived on the same web page for one year.

About European Wax Center, Inc.

European Wax Center, Inc. (NASDAQ: EWCZ) is the largest and fastest-growing franchisor and operator of out-of-home waxing services in the United States. European Wax Center locations perform more than 23 million services per year, providing guests with an unparalleled, professional personal care experience administered by highly trained wax specialists within the privacy of clean, individual waxing suites. The Company continues to revolutionize the waxing industry with its innovative Comfort Wax® formulated with the highest quality ingredients to make waxing a more efficient and relatively painless experience, along with its collection of proprietary products to help enhance and extend waxing results. By leading with its values – We Care About Each Other, We Do the Right Thing, We Delight Our Guests, and We Have Fun While Being Awesome – the Company is proud to be Certified™ by Great Place to Work®. European Wax Center, Inc. was founded in 2004 and is headquartered in Plano, Texas. Its network, which now includes more than 1,000 centers in 45 states, generated sales of $955 million in fiscal 2023. For more information, including how to receive your first wax free, please visit: https://waxcenter.com.

Forward-Looking Statements

This press release includes “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements in this press release include but are not limited to European Wax Center, Inc.’s strategy, outlook and growth prospects, its operational and financial outlook for fiscal 2024 and its long-term targets and algorithm, including but not limited to statements under the heading “Fiscal 2024 Outlook” and statements by European Wax Center’s executive. Words including “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “seek,” “should,” “will,” or “would,” or, in each case, the

 


 

negative thereof or other variations thereon or comparable terminology are intended to identify forward-looking statements. In addition, any statements or information that refer to expectations, beliefs, plans, projections, objectives, performance or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking.

These forward-looking statements are based on current expectations and beliefs. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause the Company’s actual results, performance or achievements to be materially different results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to: the operational and financial results of its franchisees; the ability of its franchisees to enter new markets, select appropriate sites for new centers or open new centers; the effectiveness of the Company’s marketing and advertising programs and the active participation of franchisees in enhancing the value of its brand; the failure of its franchisees to participate in and comply with its agreements, business model and policies; the Company’s and its franchisees’ ability to attract and retain guests; the effect of social media on the Company’s reputation; the Company’s ability to compete with other industry participants and respond to market trends and changes in consumer preferences; the effect of the Company’s planned growth on its management, employees, information systems and internal controls; the Company’s ability to retain of effectively respond to a loss of key executives; a significant failure, interruptions or security breach of the Company’s computer systems or information technology; the Company and its franchisees’ ability to attract, train, and retain talented wax specialists and managers; changes in the availability or cost of labor; the Company’s ability to retain its franchisees and to maintain the quality of existing franchisees; failure of the Company’s franchisees to implement business development plans; the ability of the Company’s limited key suppliers, including international suppliers, and distribution centers to deliver its products; changes in supply costs and decreases in the Company’s product sourcing revenue; the Company’s ability to adequately protect its intellectual property; the Company’s substantial indebtedness; the impact of paying some of the Company’s pre-IPO owners for certain tax benefits it may claim; changes in general economic and business conditions; the Company’s and its franchisees’ ability to comply with existing and future health, employment and other governmental regulations; complaints or litigation that may adversely affect the Company’s business and reputation; the seasonality of the Company’s business resulting in fluctuations in its results of operations; the impact of global crises on the Company’s operations and financial performance; the impact of inflation and rising interest rates on the Company’s business; the Company’s access to sources of liquidity and capital to finance its continued operations and growth strategy and the other important factors discussed under the caption “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended January 6, 2024 filed with the Securities and Exchange Commission (the “SEC”), as such factors may be updated from time to time in its other filings with the SEC, accessible on the SEC’s website at www.sec.gov and Investors Relations section of the Company’s website at www.waxcenter.com.

These and other important factors could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any forward-looking statement that the Company makes in this press release speaks only as of the date of such statement. Except as required by law, the Company does not have any obligation to update or revise, or to publicly announce any update or revision to, any of the forward-looking statements, whether as a result of new information, future events or otherwise.

Disclosure Regarding Non-GAAP Financial Measures

In addition to the financial measures presented in this release in accordance with U.S. Generally Accepted Accounting Principles (“GAAP”), the Company has included certain non-GAAP financial measures in this release, including Adjusted EBITDA and Adjusted net income. Management believes these non-GAAP financial measures are useful because they enable management, investors, and others to assess the operating performance of the Company.

We define EBITDA as net income (loss) before interest, taxes, depreciation and amortization. We believe that EBITDA, which eliminates the impact of certain expenses that we do not believe reflect our underlying business performance, provides useful information to investors to assess the performance of our business.

We define Adjusted EBITDA as net income (loss) before interest, taxes, depreciation and amortization, adjusted for the impact of certain additional non-cash and other items that we do not consider in our evaluation of ongoing performance of our core operations. These items include non-cash equity-based compensation expense, non-cash gains and losses on

 


 

remeasurement of our tax receivable agreement liability, contractual cash interest on our tax receivable agreement liability, transaction costs and other one-time expenses.

We define Adjusted net income (loss) as net income (loss) adjusted for the impact of certain additional non-cash and other items that we do not consider in our evaluation of ongoing performance of our core operations. These items include non-cash equity-based compensation expense, debt extinguishment costs, non-cash gains and losses on remeasurement of our tax receivable agreement liability, contractual cash interest on our tax receivable agreement liability, transaction costs and other one-time expenses. Please refer to the reconciliations of non-GAAP financial measures to their GAAP equivalents located at the end of this release.

This release includes forward-looking guidance for certain non-GAAP financial measures, including Adjusted EBITDA and Adjusted net income. These measures will differ from net income (loss), determined in accordance with GAAP, in ways similar to those described in the reconciliations at the end of this release. We are not able to provide, without unreasonable effort, guidance for net income (loss), determined in accordance with GAAP, or a reconciliation of guidance for Adjusted EBITDA and Adjusted net income (loss) to the most directly comparable GAAP measure because the Company is not able to predict with reasonable certainty the amount or nature of all items that will be included in net income (loss).

Glossary of Terms for Our Key Business Metrics

System-Wide Sales. System-wide sales represent sales from same day services, retail sales and cash collected from wax passes for all centers in our network, including both franchisee-owned and corporate-owned centers. While we do not record franchised system-wide sales as revenue, our royalty revenue is calculated based on a percentage of franchised system-wide sales, which are 6.0% of sales, net of retail product sales, as defined in the franchise agreement. This measure allows us to better assess changes in our royalty revenue, our overall center performance, the health of our brand and the strength of our market position relative to competitors. Our system-wide sales growth is driven by net new center openings as well as increases in same-store sales.

Same-Store Sales. Same-store sales reflect the change in year-over-year sales from services performed and retail sales for the same-store base. We define the same-store base to include those centers open for at least 52 full weeks. If a center is closed for greater than six consecutive days, the center is deemed a closed center and is excluded from the calculation of same-store sales until it has been reopened for a continuous 52 full weeks. This measure highlights the performance of existing centers, while excluding the impact of new center openings and closures. We review same-store sales for corporate-owned centers as well as franchisee-owned centers. Same-store sales growth is driven by increases in the number of transactions and average transaction size.

 


 

EUROPEAN WAX CENTER, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS
(Amounts in thousands, except share and per share amounts)

(Unaudited)

 

 

January 6, 2024

 

 

December 31,
2022

 

ASSETS

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

Cash and cash equivalents

 

$

52,735

 

 

$

44,219

 

Restricted cash

 

 

6,493

 

 

 

6,575

 

Accounts receivable, net

 

 

9,250

 

 

 

6,932

 

Inventory, net

 

 

20,767

 

 

 

23,017

 

Prepaid expenses and other current assets

 

 

6,252

 

 

 

5,574

 

Total current assets

 

 

95,497

 

 

 

86,317

 

Property and equipment, net

 

 

2,284

 

 

 

2,747

 

Operating lease right-of-use assets

 

 

4,012

 

 

 

4,899

 

Intangible assets, net

 

 

164,073

 

 

 

183,030

 

Goodwill

 

 

328,551

 

 

 

328,551

 

Deferred income taxes

 

 

138,215

 

 

 

106,187

 

Other non-current assets

 

 

3,094

 

 

 

4,301

 

Total assets

 

$

735,726

 

 

$

716,032

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

Accounts payable and accrued liabilities

 

$

17,966

 

 

$

18,547

 

Long-term debt, current portion

 

 

4,000

 

 

 

4,000

 

Tax receivable agreement liability, current portion

 

 

9,363

 

 

 

4,867

 

Deferred revenue, current portion

 

 

5,261

 

 

 

4,084

 

Operating lease liabilities, current portion

 

 

1,232

 

 

 

1,312

 

Total current liabilities

 

 

37,822

 

 

 

32,810

 

Long-term debt, net

 

 

372,000

 

 

 

370,935

 

Tax receivable agreement liability, net of current portion

 

 

197,273

 

 

 

167,293

 

Deferred revenue, net of current portion

 

 

6,615

 

 

 

6,901

 

Operating lease liabilities, net of current portion

 

 

3,158

 

 

 

4,227

 

Other long-term liabilities

 

 

2,246

 

 

 

3,562

 

Total liabilities

 

 

619,114

 

 

 

585,728

 

Commitments and contingencies

 

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

 

Preferred stock ($0.00001 par value, 100,000,000 shares authorized, none issued and outstanding as of January 6, 2024 and December 31, 2022, respectively)

 

 

 

 

 

 

Class A common stock ($0.00001 par value, 600,000,000 shares authorized, 51,261,001 and 45,277,325 shares issued and 48,476,981 and 44,561,685 outstanding as of January 6, 2024 and December 31, 2022, respectively)

 

 

 

 

 

 

Class B common stock ($0.00001 par value, 60,000,000 shares authorized, 12,278,876 and 18,175,652 shares issued and outstanding as of January 6, 2024 and December 31, 2022, respectively)

 

 

 

 

 

 

Treasury stock, at cost, 2,784,020 and 715,640 shares of Class A common stock as of January 6, 2024 and December 31, 2022, respectively

 

 

(40,000

)

 

 

(10,080

)

Additional paid-in capital

 

 

232,848

 

 

 

207,517

 

Accumulated deficit

 

 

(109,506

)

 

 

(118,437

)

       Total stockholders’ equity attributable to European Wax Center, Inc.

 

 

83,342

 

 

 

79,000

 

Noncontrolling interests

 

 

33,270

 

 

 

51,304

 

Total stockholders’ equity

 

 

116,612

 

 

 

130,304

 

Total liabilities and stockholders’ equity

 

$

735,726

 

 

$

716,032

 

 

 


 

EUROPEAN WAX CENTER, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

(Amounts in thousands)

(Unaudited)

 

 

 

For the Fourteen Weeks Ended

 

 

For the Years Ended

 

 

 

January 6, 2024

 

 

December 31, 2022

 

 

January 6, 2024

 

 

December 31, 2022

 

REVENUE

 

 

 

 

 

 

 

 

 

 

 

 

Product sales

 

$

31,812

 

 

$

30,900

 

 

$

125,269

 

 

$

117,745

 

Royalty fees

 

 

13,509

 

 

 

12,493

 

 

 

53,352

 

 

 

49,733

 

Marketing fees

 

 

7,626

 

 

 

7,077

 

 

 

29,994

 

 

 

28,041

 

Other revenue

 

 

3,378

 

 

 

3,053

 

 

 

12,409

 

 

 

11,832

 

Total revenue

 

 

56,325

 

 

 

53,523

 

 

 

221,024

 

 

 

207,351

 

OPERATING EXPENSES

 

 

 

 

 

 

 

 

 

 

 

 

Cost of revenue

 

 

15,559

 

 

 

16,059

 

 

 

62,637

 

 

 

59,227

 

Selling, general and administrative

 

 

13,716

 

 

 

14,593

 

 

 

59,485

 

 

 

58,951

 

Advertising

 

 

9,277

 

 

 

5,656

 

 

 

33,869

 

 

 

28,659

 

Depreciation and amortization

 

 

5,022

 

 

 

5,057

 

 

 

20,170

 

 

 

20,231

 

Loss on disposal of assets and non-cancellable contracts

 

 

7

 

 

 

2

 

 

 

7

 

 

 

7

 

Total operating expenses

 

 

43,581

 

 

 

41,367

 

 

 

176,168

 

 

 

167,075

 

Income from operations

 

 

12,744

 

 

 

12,156

 

 

 

44,856

 

 

 

40,276

 

Interest expense, net

 

 

6,591

 

 

 

7,235

 

 

 

26,686

 

 

 

23,626

 

Other (income) expense

 

 

344

 

 

 

55,926

 

 

 

(412

)

 

 

56,228

 

Income (loss) before income taxes

 

 

5,809

 

 

 

(51,005

)

 

 

18,582

 

 

 

(39,578

)

Income tax expense (benefit)

 

 

2,198

 

 

 

(53,274

)

 

 

6,236

 

 

 

(53,191

)

NET INCOME

 

$

3,611

 

 

$

2,269

 

 

$

12,346

 

 

$

13,613

 

Less: net income attributable to noncontrolling interests

 

 

1,125

 

 

 

1,367

 

 

 

3,415

 

 

 

6,336

 

NET INCOME ATTRIBUTABLE TO EUROPEAN WAX CENTER, INC.

 

$

2,486

 

 

$

902

 

 

$

8,931

 

 

$

7,277

 

 

 


 

EUROPEAN WAX CENTER, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Amounts in thousands)

(Unaudited)

 

 

 

For the Years Ended

 

 

 

January 6, 2024

 

 

December 31,
2022

 

Cash flows from operating activities:

 

 

 

 

 

 

Net income

 

$

12,346

 

 

$

13,613

 

Adjustments to reconcile net income to net cash provided by
   operating activities:

 

 

 

 

 

 

Depreciation and amortization

 

 

20,170

 

 

 

20,231

 

Amortization of deferred financing costs

 

 

5,417

 

 

 

3,852

 

Gain on interest rate cap

 

 

 

 

 

(196

)

Loss on debt extinguishment

 

 

 

 

 

1,957

 

Provision for inventory obsolescence

 

 

(63

)

 

 

(66

)

Provision for bad debts

 

 

129

 

 

 

76

 

Loss on disposal of property and equipment

 

 

11

 

 

 

7

 

Deferred income taxes

 

 

5,623

 

 

 

(53,714

)

Remeasurement of tax receivable agreement liability

 

 

(512

)

 

 

56,228

 

Equity-based compensation

 

 

10,988

 

 

 

9,033

 

Changes in assets and liabilities:

 

 

 

 

 

 

Accounts receivable

 

 

(2,701

)

 

 

(802

)

Inventory, net

 

 

2,313

 

 

 

(3,528

)

Prepaid expenses and other assets

 

 

1,213

 

 

 

3,186

 

Accounts payable and accrued liabilities

 

 

529

 

 

 

(5,694

)

Deferred revenue

 

 

891

 

 

 

1,194

 

Other long-term liabilities

 

 

(752

)

 

 

(1,022

)

Net cash provided by operating activities

 

 

55,602

 

 

 

44,355

 

Cash flows from investing activities:

 

 

 

 

 

 

Purchases of property and equipment

 

 

(785

)

 

 

(245

)

Net cash used in investing activities

 

 

(785

)

 

 

(245

)

Cash flows from financing activities:

 

 

 

 

 

 

Proceeds on long-term debt

 

 

 

 

 

384,328

 

Principal payments on long-term debt

 

 

(4,000

)

 

 

(182,000

)

Deferred loan costs

 

 

 

 

 

(12,419

)

Payments of debt extinguishment costs

 

 

 

 

 

(77

)

Distributions to EWC Ventures LLC members

 

 

(3,398

)

 

 

(8,697

)

Payment of Class A common stock offering costs

 

 

 

 

 

(870

)

Repurchase of Class A common stock

 

 

(29,920

)

 

 

(10,080

)

Taxes on vested restricted stock units paid by withholding shares

 

 

(537

)

 

 

(643

)

Dividends to holders of Class A common stock

 

 

 

 

 

(122,227

)

Dividend equivalents to holders of EWC Ventures units

 

 

(2,849

)

 

 

(83,020

)

Payments pursuant to tax receivable agreement

 

 

(5,679

)

 

 

(912

)

Net cash used in financing activities

 

 

(46,383

)

 

 

(36,617

)

Net increase in cash, cash equivalents and restricted cash

 

 

8,434

 

 

 

7,493

 

Cash, cash equivalents and restricted cash, beginning of period

 

 

50,794

 

 

 

43,301

 

Cash, cash equivalents and restricted cash, end of period

 

$

59,228

 

 

$

50,794

 

Supplemental cash flow information:

 

 

 

 

 

 

Cash paid for interest

 

$

22,244

 

 

$

18,460

 

Cash paid for income taxes

 

$

860

 

 

$

169

 

Non-cash investing activities:

 

 

 

 

 

 

Property purchases included in accounts payable and accrued liabilities

 

$

 

 

$

37

 

Right-of-use assets obtained in exchange for operating lease obligations

 

$

368

 

 

$

 

 

 

 

 

 

 


 

Reconciliation of GAAP net income to Adjusted net income:

 

 

For the Fourteen Weeks Ended

 

 

For the Years Ended

 

 

 

January 6, 2024

 

 

December 31, 2022

 

 

January 6, 2024

 

 

December 31, 2022

 

(in thousands)

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

$

3,611

 

 

$

2,269

 

 

$

12,346

 

 

$

13,613

 

Equity-based compensation(1)

 

 

1,499

 

 

 

1,580

 

 

 

10,988

 

 

 

9,033

 

Remeasurement of tax receivable agreement liability (2)

 

 

344

 

 

 

55,926

 

 

 

(412

)

 

 

56,228

 

Transaction costs (3)

 

 

 

 

 

 

 

 

 

 

 

1,405

 

Other (4)

 

 

 

 

 

406

 

 

 

 

 

 

666

 

Loss on extinguishment of debt

 

 

 

 

 

 

 

 

 

 

 

1,957

 

Tax effect of adjustments to net income (5)

 

 

546

 

 

 

(11,451

)

 

 

(389

)

 

 

(11,451

)

Adjusted net income

 

$

6,000

 

 

$

48,730

 

 

$

22,533

 

 

$

71,451

 

 

(1) Represents non-cash equity-based compensation expense.
(2) Represents non-cash expense related to the remeasurement of our tax receivable agreement liability and contractual cash interest paid on our tax receivable agreement liability.

(3) Represents costs related to our Secondary offering of Class A common stock by selling stockholders and certain costs incurred in connection with our securitization transaction.

(4) Represents non-core operating expenses identified by management. For fiscal year 2022 these costs relate to executive severance.

(5) Represents the income tax impact of non-GAAP adjustments computed by applying our estimated blended statutory tax rate to our share of the identified items and incorporating the effect of nondeductible and other rate impacting adjustments.

 

Reconciliation of GAAP net income to EBITDA and Adjusted EBITDA:

 

 

For the Fourteen Weeks Ended

 

 

For the Years Ended

 

 

 

January 6, 2024

 

 

December 31, 2022

 

 

January 6, 2024

 

 

December 31, 2022

 

(in thousands)

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

$

3,611

 

 

$

2,269

 

 

$

12,346

 

 

$

13,613

 

Interest expense, net

 

 

6,591

 

 

 

7,235

 

 

 

26,686

 

 

 

23,626

 

Income tax expense (benefit)

 

 

2,198

 

 

 

(53,274

)

 

 

6,236

 

 

 

(53,191

)

Depreciation and amortization

 

 

5,022

 

 

 

5,057

 

 

 

20,170

 

 

 

20,231

 

EBITDA

 

$

17,422

 

 

$

(38,713

)

 

$

65,438

 

 

$

4,279

 

Equity-based compensation(1)

 

 

1,499

 

 

 

1,580

 

 

 

10,988

 

 

 

9,033

 

Remeasurement of tax receivable agreement liability (2)

 

 

344

 

 

 

55,926

 

 

 

(412

)

 

 

56,228

 

Transaction costs (3)

 

 

 

 

 

 

 

 

 

 

 

1,405

 

Other (4)

 

 

 

 

 

406

 

 

 

 

 

 

666

 

Adjusted EBITDA

 

$

19,265

 

 

$

19,199

 

 

$

76,014

 

 

$

71,611

 

Adjusted EBITDA margin

 

 

34.2

%

 

 

35.9

%

 

 

34.4

%

 

 

34.5

%

 

(1) Represents non-cash equity-based compensation expense.
(2) Represents non-cash expense related to the remeasurement of our tax receivable agreement liability and contractual cash interest paid on our tax receivable agreement liability.

(3) Represents costs related to our Secondary offering of Class A common stock by selling stockholders and certain costs incurred in connection with our securitization transaction.

(4) Represents non-core operating expenses identified by management. For fiscal year 2022 these costs relate to executive severance.

 

Investor Contact

European Wax Center, Inc.

Bethany Johns

IR@myewc.com

469-270-6888

 

Edelman Smithfield for European Wax Center

EWCIR@edelman.com

 

 


 

Media Contact

Creative Media Marketing

Carolanne Coviello

Ewc@cmmpr.com

212-979-8884 ext 209